Oruka Therapeutics Inc ORKA

$99.55 +4.12 (4.32%)

Valuation

Market cap
6,318,420,000
Revenue TTM
$0
Net income TTM
$-105,430,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
822,100
Avg volume
920,194
Day's range
$95.29 – $101.41
Shares out
66,210,000
Stochastic %K
92%
Beta
-0.34
Analysts
Strong Buy
Price target
$143.36

Price

Company profile

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phas...

Show more

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Industry
Biotechnology
Sector
Healthcare
Phone
650 606 7910
Website
https://orukatx.com
Address
855 Oak Grove Avenue, Suite 100, Menlo Park, United States

Latest news

Stocktwits

thesheiktrader Nov 3, 6:50 PM
$ORKA noviembre will be crucial, we can have one best performance on the year before the results of 52 week
1 replies
Merlintrader Nov 3, 5:15 PM
Oruka $ORKA will present at four investor conferences in November. Guggenheim Nov 10, Stifel Nov 11, UBS Nov 17 and Jefferies Nov 18. Shares closed at $95.43 on Monday, above the SMA50 and above the SMA200, RSI 64. More details in our hub. Not investment advice.
0 replies
Merlintrader Nov 1, 12:34 AM
$ORKA closed the week at $96.87 (+20.9% w/w, +0.2% Friday), above the 50-day SMA ($88.47) and above the 200-day ($69.23). RSI14 67.2. Support $70.50, resistance $98.88 (20-day range, top). New hub updated: https://www.merlintrader.com/oruka-therapeutics-orka-stock-hub/
0 replies
AlertsAndNews Oct 28, 11:46 PM
Alright highlights of the week so far. $AIOK $GMAB $SGRY $BOOM $ORKA and more... Let's do it again tomorrow. Link in bio for more. All trading and investing involves a risk of loss. Do your own due diligence always!
0 replies
thesheiktrader Oct 28, 9:41 PM
$ORKA see u guys in 130$
0 replies
Whiskeyunderthebed Oct 28, 3:04 PM
$ORKA This will go to $120
0 replies
WAJeff Oct 28, 3:00 PM
$ORKA Midcap that has had too few eyes on it all year
0 replies
FlashAim Oct 27, 5:44 PM
$ORKA $INDP $TRAX Watch-list7
0 replies